$8.53
0.10[1.19%]
Last update: 9:23AM Get Real Time Here
Coya Therapeutics
(NASDAQ:COYA)Coya Therapeutics Stock (NASDAQ:COYA), Analyst Ratings, Price Targets, Predictions
Coya Therapeutics Inc has a consensus price target of $19, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from Chardan Capital, EF Hutton, and Chardan Capital on March 20, 2024, August 9, 2023, and August 9, 2023. With an average price target of $17.67 between Chardan Capital, EF Hutton, and Chardan Capital, there's an implied 107.11% upside for Coya Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
EF Hutton
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Coya Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/20/2024 | COYA | Buy Now | Coya Therapeutics | $8.53 | 64.13% | Chardan Capital | Keay Nakae | $11 → $14 | Maintains | Buy | Get Alert |
| 08/09/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 228.25% | EF Hutton | Elemer Piros | → $28 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 28.96% | Chardan Capital | Keay Nakae | → $11 | Reiterates | Buy → Buy | Get Alert |
| 07/18/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 28.96% | Chardan Capital | Keay Nakae | → $11 | Reiterates | Buy → Buy | Get Alert |
| 07/18/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 228.25% | EF Hutton | Elemer Piros | → $28 | Reiterates | Buy → Buy | Get Alert |
| 07/17/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 28.96% | Chardan Capital | Keay Nakae | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 28.96% | Chardan Capital | Keay Nakae | $9 → $11 | Maintains | Buy | Get Alert |
| 06/07/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 228.25% | EF Hutton | Elemer Piros | → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/18/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 75.85% | BTIG | Thomas Shrader | → $15 | Initiates | → Buy | Get Alert |
| 05/17/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 5.51% | Chardan Capital | Keay Nakae | → $9 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 228.25% | EF Hutton | Elemer Piros | → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 228.25% | EF Hutton | Elemer Piros | → $28 | Reiterates | Buy → Buy | Get Alert |
| 05/03/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 228.25% | EF Hutton | Elemer Piros | → $28 | Initiates | → Buy | Get Alert |
| 03/30/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 5.51% | Chardan Capital | Keay Nakae | → $9 | Reiterates | → Buy | Get Alert |
| 03/22/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 5.51% | Chardan Capital | Keay Nakae | → $9 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | COYA | Buy Now | Coya Therapeutics | $8.53 | 5.51% | Chardan Capital | Keay Nakae | → $9 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Coya Therapeutics (COYA)?
The latest price target for Coya Therapeutics (NASDAQ: COYA) was reported by Chardan Capital on March 20, 2024. The analyst firm set a price target for $14.00 expecting COYA to rise to within 12 months (a possible 64.13% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Coya Therapeutics (COYA)?
The latest analyst rating for Coya Therapeutics (NASDAQ: COYA) was provided by Chardan Capital, and Coya Therapeutics maintained their buy rating.
When was the last upgrade for Coya Therapeutics (COYA)?
There is no last upgrade for Coya Therapeutics.
When was the last downgrade for Coya Therapeutics (COYA)?
There is no last downgrade for Coya Therapeutics.
When is the next analyst rating going to be posted or updated for Coya Therapeutics (COYA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coya Therapeutics was filed on March 20, 2024 so you should expect the next rating to be made available sometime around March 20, 2025.
Is the Analyst Rating Coya Therapeutics (COYA) correct?
While ratings are subjective and will change, the latest Coya Therapeutics (COYA) rating was a maintained with a price target of $11.00 to $14.00. The current price Coya Therapeutics (COYA) is trading at is $8.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.